News
[
Medical Device Contract Manufacturing Market Size: Trends
]
Key Takeaways
- The global medical device contract manufacturing market may grow from USD 83.77 billion in 2025 to USD 140.84 billion in 2030. The forecast CAGR is 10.9%, according to MarketsandMarkets.
- That change equals about 68% over five years. It is not a one-year jump. The rate is also above one forecast for the wider medical device market. The two reports use different scopes. The MarketsandMarkets forecast covers contract manufacturing, while Technavio’s forecast covers the wider medical device market.
- Main service groups include device design and production, packing and assembly, and quality work, as outlined by MarketsandMarkets.
- OEMs should review design, quality, supply, and scale, not capacity alone.
- Costa Rica may fit a nearshoring plan when its site, skills, lanes, and total cost fit the product.
Medical device OEMs must launch complex products faster. They must also meet strict rules for quality, records, and supply. These needs are helping grow the medical device contract manufacturing market size. More OEMs now use outside partners for design, production, quality, packing, and assembly, according to MarketsandMarkets.
The headline market number needs context. This forecast covers outside services for medical devices. It does not cover all sales of finished devices. It also raises a key buying question. Can a partner support your product from design to full-scale production?
Medical Device Contract Manufacturing Market Snapshot
This view shows more than market value. It also shows the services, products, risk classes, and regions that shape a partner search.
Understanding the Medical Device Contract Manufacturing Market Size
“Market size” can mean more than one thing. In this forecast, it means outside work for medical device design and production. It also covers packing, assembly, testing, and quality work. It is not the same as the wider market for finished medical devices, as defined in the MarketsandMarkets report.
MarketsandMarkets published this forecast in July 2025. Its base year is 2024. It puts the market at USD 83.77 billion in 2025 and USD 140.84 billion in 2030. That is a rise of about 68% over five years. The stated CAGR is 10.9%.
A second report gives useful context. Technavio forecasts a 6.3% CAGR for the wider medical device market from 2025 to 2030. The 10.9% rate is higher. Still, this is a direction, not a direct ranking. The reports define their markets in different ways.
The main message is simple. Outside medical device work is forecast to grow fast. The forecast is useful for planning. It does not replace a review of your volume, risk, supply, and total cost.
Why OEMs Are Rethinking Their Manufacturing Strategy
Many devices now use electronics, sensors, links, special materials, and complex builds. An OEM that keeps all work in-house may need new tools, staff, tests, suppliers, records, and quality controls, according to the MarketsandMarkets report.
The MarketsandMarkets report also points to strict rules, high upgrade costs, robots, and automation. These forces create a choice. An OEM can build each skill in-house. Or it can use a partner with key tools and staff already in place.
Outside work does not always mean lower cost. The gain may come from fewer handoffs, less rework, better records, and a smoother ramp. OEMs should compare the full cost, not just the unit price.
Costa Rica’s Role in a Nearshoring Strategy
Costa Rica is one option for nearshoring. It may suit OEMs that want a site closer to North American markets. Location alone is not enough to prove fit.
East West’s medical manufacturing page lists Costa Rica, Mexico, Vietnam, and the United States in its global medical network. Its diagnostics, devices and equipment, and surgical systems pages also describe design, sample builds, production, supply, and ISO 13485 site skills. OEMs should confirm the exact site, process, records, freight plan, and landed cost for each program.
Costa Rica should be treated as a fit test, not a blanket answer. The choice should reflect product risk, customer location, volume, part sources, lead time, rules, and total landed cost.
What OEMs Should Evaluate in a Contract Manufacturing Partner
Capacity matters. Capacity alone does not show if a partner can move a regulated device from a sample to repeatable production. OEMs should review four linked skills.
- Bring the design team in early. Early review can find material, test, build, and process risks before they cost more to fix.
- Review quality through proof, not labels. Ask how the site controls tests, defects, fixes, design changes, and trace records for your product.
- Review supply beyond buying. Ask how the partner checks suppliers, watches part risk, controls changes, and plans for a shortage.
- Then test scale. A partner may build a sample well but lack the systems for a steady ramp. That gap can cause a second move and new test work.
East West supports diagnostics, devices and equipment, and surgical systems. Its medical pages position the company as a design, production, and supply partner for these areas.
Trends Shaping the Market Through 2030
The forecast points to more than higher sales. It also points to more complex products and more use of automated tools, according to MarketsandMarkets.
This makes the partner part of the product plan. The partner may need to help with design transfer, process work, automation, quality, supply, and regional production.
It also changes how OEMs should compare bids. A low unit price may not win if the site has long lead times, weak change control, or little design support.
What the Market Outlook Means for OEMs
The medical device contract manufacturing market size is forecast to grow fast. That growth does not choose a partner for you. It does show why OEMs are reviewing outside design, production, quality, and supply as one plan.
Use this check before you start a partner review:
If you are comparing nearshoring sites or preparing a medical device for launch, East West can review your needs across design, production, quality, and supply.
Discuss Your Medical Device Manufacturing Program With East West
Frequently Asked Questions
Demand for complex devices, more health care access, automation, strict rules, and the need to avoid costly plant upgrades are key drivers. The MarketsandMarkets forecast gives a 10.9% CAGR from 2025 to 2030.
The MarketsandMarkets report lists device design and production, packing and assembly, and quality work. Related work can include engineering, checks, tests, sterilization, packing, and assembly.
Costa Rica can be reviewed as a nearshoring site close to North American markets. The choice should account for product risk, quality, freight, supply, and total landed cost. East West’s medical manufacturing page provides the nearshoring context.
Review design, quality, rule experience, supplier control, scale, and life-cycle support. Ask for proof from the exact site and process.
One partner can link design, samples, production, quality, packing, and supply. This may cut handoff risk during launch when the partner has the right skills, as described across East West’s medical manufacturing, diagnostics, devices and equipment, and surgical systems pages.
Contact us to
learn more.
Today, East West + Vexos provides design, manufacturing, and supply chain solutions with 20+ years of experience and best-in-class capabilities. No matter how unique the project, East West can help you solve it.
Thank you!
Sorry! Seems like there's been an error
